within the l. plantarum species several strains have successfully improved glycemic control and had anti-obesity effects in animals - and t2d patients  table .the species l. rhamnosus l. casei and l. paracasei form a closely related taxonomic group  fig.

different probiotic mechanisms are displayed using the examples of l. rhamnosus gg l. acidophilus ncfm l. gasseri 2055 l. casei shirota and l. plantarum wfsc1.

obesity- associated intestinal dysbiosis triggers intestinal inflammation increased permeability of the intestinal epithelium and changes in the intestinal metabolome.

phylogenetic trees are based on 16 s rrna sequences adapted from  l. casei strains 431 ccfm0412 and shirota improved glucose tolerance in animals - and l. casei shirota reduced the effects of a high-fat diet hfd in healthy individuals .several l. paracasei strains improved glycemic control in animals   or restored liver function in diet- induced hypercholesterolemic animals  .l.

effects of lactobacillus paracasei cncm i-4034 bifidobacter- ium breve cncm i-4035 and lactobacillus rhamnosus cncm i- 4036 on hepatic steatosis in zucker rats.

lactis420 dio mice1010 cfu day6fbg -19 bg120 nsndweight gain -33 fm nsnslps -55i-2494 hfd-obese mice108 cellsday12homa- ir -50 fbg nsoggt -31ndweight gain -43ndlbp -17adiponectin 20hn019 patients with mets 3 x 1010cfudaylongum7homa-ir ns fbg nsinsulin nstg ns ldl -15tc -8 hdl nsbmi -4ndndtnf-a -28 il-6 -10bl1 hyper-1.4 x 1093ndtg -10bw nsndndndcholesterolemic rats cellsdayldl -70tc -28 hdl nsweight gain nsadolescentishealthy men3.7 x 108 4fbg nstg nsldl ns tc ns hdl nsbmi nsndincreased fecal frequencyatcc 15705western diet fed mice2 x 108cfuday12fbg nsweight gain nsalt nsoccludin60 zo-1 47l66-5 hfd-obese rats0.4 x 108cfudayl75-4 hfd-obese rat0.4 x 108cfuday6homa-ir ns fbg ns bg120 ns ogtt nsinsulin ns6homa-ir ns fbg ns bg120 ns ogtt nsinsulin nstg -42tc -56tg -47 tc nsweight gain -21ndndndweight gain -20ndndndendocrine 2017 58207-227215the effects of specific probiotic strains with beneficial effects on t2d and metabolism.probiotic strains with beneficial impact on t2d andor obesitybifidobacterium and lactobacillus strains are the most widely used bacteria exhibiting probiotic properties regarding t2d andor obesity.

the lactobacillus plantarum l. plantarum strain 299 v is beneficial in the treatment of irritable bowl syndrome ibs   while l. plantarum strain mf1298 increases symptoms of ibs .

.the intestinal microbiota in metabolic disorders and t2denvironmental factors such as diet and antibiotics have dramatic effects on the host's intestinal microbiota compo- sition .

it is therefore necessary to considertable 1 probiotic strains with antiobesity and antidiabetic effects in animals andor humanslgg stz-induced diabetic rats0.4 gday9fbg ns hba1c -16 insulin 60ndbw nsndndnd kk-ay t2d mice 2 adlibitum6fbg -39hba1c -10insulin nsndbw nsndndnd high-fructoseinduced nafld mice2 x 108cfuday8ndtg -109bw ns weight gain nsalt -75occludin 52 claudin 95 lps -150tnf-a -100il-1b -150il-8 -333hfd-mice108 cfu day13fbg -50ndbw nsnsndadiponectin -120pregnant women and their newborns1011 cfuday16ndndweight gain nsndndndadiponectin incolostrum 13 children with nafld1.2 x 1010cfuday8ndndbmi ns visceral fat nsalt -75ndtnf-a nsno adverse effects reportedcgmcc 1.3724 obese women3.2 x 108cfuday24insulin -29 ldl ns tc ns hdl nsbw -7ndndcrp nsleptin -28 adiponectin nsno adverse effects reportedcrl981 stz-induceddiabetic miceunclear4fbg -40hba1c -24tg -46ldl -20tc -270 hdl nsndast nsalt nsndsod 44 catalase nscncm i- obese zucker-lepr- 1010 cfu4homa-ldl nsndast nslps -70tnf-a -257 leptin ns4036ratsdayir ns fbg nsinsulin nstc ns hdl 40alt -17adiponectin -35pl60 dio-mice109 cfuday8fbg -77ldl -29 tc ns hdl -15weight gain -60epi -43mesenteric fat -33perirenal fat -38bw -27leptin -107i-3690 dio-mice108 cells daycasei12homa- ir -50 fbg -37insulin -37ndweight gain -55ndndleptin nsmda ns431 dio mice1.6 x 109cfuday8ndndndndndtnf-a -78il-6 ns inf-g ns il-10 nsliver immune cells cd8  nscd4  -50 f480 41ccfm0412  hfd stz-induceddiabetic mice109 cfuday12ogtt -30hba1c -30insulin 32tg -23ldl -22.8tc -31 hdl 15nandndtnf-a -17 il-6 -522 gsh endotoxin -2415 mda -24 ros -25 sod 30shirota dio rats108 cfu intragastric injectionimmediate responsendndndndndndneuronal activity in brownand white adipose tissue.table 1 continued4034ratsdayir -85 fbg nsinsulin nstc ns hdl nsalt nsil-6 -172g15 hfd stz-induced diabetic ratsq14 hfd stz-induced diabetic rats8 x 108cfuday8 x 108cfudayfbg -50hba1c -366fbg -80hba1c -50ndndndlps -37il-6 -14 il-1b -40il-8 -30ndndndlps -29il-6 -10il-1b -55 il-8 -44f19 dio mice2 x 109cfuday10ndtg 37 ldl ns tc ns hdl nsfm -23ndndndangptl4 75ntu 101  hyper-cholesterolemic syrian hamstersunclear8ndtg -43ldl -48tc -27 hdl nsbw -13ndndnd obese rats150 mgdaygasseri2055 dio-mice2.5 x 106cfuday2ndndbw -11 epi -26mesenteric fat -15perirenal fat -31ndnd healthy subjects5 x 109cfuday2fbg nstg ns ldl ns tc -7 hdl nsbmi -16 bw nsggt ns ast ns alt nsndndfecal fat level 75 human subjects with high bmi1011 cfuday12ndndbw -1.4 bmi -1.5abdominal visceralfat -5.8 subcutaneousfat -3.3ndndadiponectin nsbnr17 dio-mice1010 cfuday10fbg ns insulin -167ldl ns tc ns hd nsbw -9epi -37mesenteric fat -46perirenal fat -38ndndtnf-a nsleptin -580 adiponectin nstable 1 continuedprobioticref systemdosageduration weeksglycemic control change lipid profile change body weight change liver function change gut per-meability changeinflammation change other measurements observationscurvatusdbdb mice2 x 1010 cfuday12fbg -329hba1c -18ndbw nsndndndhy7601 dio mice1010 cfudayreuteri9ndtg ns ldl -14 tc -18ndndndtnf-a nsil-6 ns il-1b nsgmnl-263  hfrd stz-induced 109 cells4fbg -20ndnandndnddecrease indiabetic ratsdayhba1c -33phosphorylation of jak2 stat1.reduced expression of pai-1 p21alpha sma andfibronectin.hfrd rats2 x 109 cfuday14hmoa- ir -21 fbg nsogtt -19hba1c -15insulin -43tg -185ldl -180tc -40bw -13ast -50alt -33ndtnf-a -82 il-6 -19 leptin -67gsh -25 sod 54dsm 17938 t2d patients1010 cfuday12homa- ir ns hba1c  nstg ns ldl ns tc ns hdl nsbmi ns bw nsast ns alt ns ndndatcc 6475plantarumdio mice3.5 x 105 cfuday12ndndbw -44ndndnddsm15313  dio-mice7 x 109cfuday20fbg -17insulin nstg ns tc nsndndndadiponectin nsph04 hyper-cholesterolaemic mice107 cfuday2ndtg -10tc -7bw nsndndndncu116 hfd inducednafld-mice hfd stz-induced diabetic ratsccfm0236  hfd stz-induceddiabetic mice109 cfuday3 x 109cfuday8 x 109cfu ml day5fbg -53insulin -67fbg -37insulin -678homa-ir -142 fbg ns bg120 -78ogtt -55insulin -66tg -34tc -54 hdl 13tg -43tc -60ldl -167 hdl 13tg -14 ldl ns tc ns hdl 52ndast -16 alt -27 lps -33tnf-a -20 il-6 -36 leptin -32 gsh 15mda -31 sod 92leptin -70 gsh18 mda -44 cat 18ndndndtnf-a -19 il-6 ns il-10 -13leptin -10 gsh65 mda -40sod -44wcfs1 healthy humans1012 cfuinfusion into duodenumzo-125 occludin nstable 1 continuedprobioticref systemdosageduration weeksglycemic control change lipid profile change body weight change liver function change gut per-meability changeinflammation change other measurements observationstn627 aloxan-induceddiabetic rats2 x 108cfuday4fbg -75bg120 -71tg -43ldl -94 hdl 58bw nsast -103alt -116ndndk68 hfd hfrd rats109 cfuday8homa-ir -29fbg -9 hba1c nsinsulin -17tg -12 ldl ns tc ns hdl nsbw -9weight gain -13epi -12ndndleptin -62 adiponectin 16k21 dio mice109 cfuday8fbg -8insulin -50tg -49tc -15bw -7.5weight gain -50epi -27ast -285alt -59ndleptin -127 adiponectin nspl62 dio-mice109 cfudaytg -150 ldl ns tc ns hdl nsbw -17weight gain -22 epi nsmesenteric fat ns perirenal fatnsndndnda7 dio-mice108 cfuday2ndtg -20ldl -18tc -7 hdl nsndndndnd t2d patients4 x 109 cfuday8ndndndndndsod -5oll2712  hfd-mice109 cfuday12homa- ir nsbg120 -71tg ns tc nsbw ns epi nsndndtnf-a nsil-6 -18 il-1b -162lg42 dio mice109 cfuday12insulin -160 tg -23 ldl ns tc ns hdl nsweight gain -57ndndleptin -58tn8 hfd-obese rats109 cellsday4ndtg -124tc -120 hdl 27bw -68ggt -86ast -13alt -209ndndno.

gasseri strains sbt2055 and bnr17 showed anti- obese and anti-diabetic effects in hfd-mice - and sbt2055 showed promising anti-obesity effects when used in overweight adults  .only one strain of the l. curvatus species has been reported in the context of obesity andor diabetes.

while ben- eficial effects of l. paracasei ntu 101 on the host's immune response declined within the first week after treatment cessation persistence of the effects correlated directly with length of probiotic treatment .

sinha oral administration of dahi con- taining probiotic lactobacillus acidophilus and lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats.

servin individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain lactobacillus johnsonii ncc933 and vaginal strain lactobacillus gasseri ks120.1 against enteric uropathogenic and vaginosis- associated pathogens.

within the lactobacillus genus at least eight species demonstrated anti-obesity or anti-diabetic effects in animal models or humans.l.

regulation of human epithelial tight junction proteins by lactobacillus plan- tarum in vivo and protective effects on the epithelial barrier.

